Evidence map›Paper›PMID 32172409›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Medical cannabis in supportive cancer care: lessons from Canada.

Maria Fernanda Arboleda, Erin Prosk, Claude Cyr, Rihab Gamaoun, Antonio Vigano

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Maria Fernanda ArboledaResearch Department, Santé Cannabis, 4150 Saint-Catherine St W Suite 225, Montreal, Quebec, H3Z 2Y5, Canada. mfarboleda@santecannabis.ca.
Erin ProskResearch Department, Santé Cannabis, 4150 Saint-Catherine St W Suite 225, Montreal, Quebec, H3Z 2Y5, Canada.
Claude CyrDepartment of Family Medicine, McGill University, 5858 Ch de la Côte des Neiges, Montreal, Quebec, H3S 1Z1, Canada.
Rihab GamaounResearch Department, Santé Cannabis, 4150 Saint-Catherine St W Suite 225, Montreal, Quebec, H3Z 2Y5, Canada.
Antonio ViganoResearch Department, Santé Cannabis, 4150 Saint-Catherine St W Suite 225, Montreal, Quebec, H3Z 2Y5, Canada.
McGill University Health Centre · CASante Montreal · CAMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments. But the majority of healthcare practitioners still feel unprepared and insufficiently informed to make reasonable, evidence-based recommendations about medical cannabis. More than 30 countries worldwide have now legalized access to medical cannabis; yet various nations still face arduous regulatory challenges to fulfill the needs of patients, healthcare practitioners, and other medical stakeholders. This has affected the deployment of comprehensive medical cannabis access programs adapted to cultural and social realities. With a 20-year history of legal medical cannabis access and nearly 400,000 registered patients under its federal access program, Canada serves as a model for countries which are developing their regulatory frameworks. The Canadian clinical experience in cannabinoid-based treatments is also a valuable source of lessons for healthcare professionals who wish to better understand the current evidence examining medical cannabis for oncology patients.

Indexed as

CanadaDrug and Narcotic ControlEmotionsGovernment RegulationHumansMedical MarijuanaNeoplasmsPalliative CareMedical MarijuanaCanadian experienceMedical cannabisSupportive cancer care

Identifiers

PMID32172409
OpenAlexW3010933006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.